[no definition available]
EC 2.3.1.-;
Aminoglycoside N-acetyltransferase;
Enhanced intracellular survival protein;
Protein-lysine N-acetyltransferase
| Timeframe | Studies on this Protein(%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Drug | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Publication(s) |
|---|---|---|---|---|---|
| bromperidol | Mycobacterium tuberculosis H37Rv | IC50 | 0.5200 | 1 | 1 |
| bromperidol | Mycobacterium tuberculosis H37Rv | Ki | 0.2400 | 1 | 1 |
| droperidol | Mycobacterium tuberculosis H37Rv | IC50 | 12.2000 | 1 | 1 |
| haloperidol | Mycobacterium tuberculosis H37Rv | IC50 | 0.3900 | 1 | 1 |
| haloperidol | Mycobacterium tuberculosis H37Rv | Ki | 0.3900 | 1 | 1 |
| 4(4-chlorophenyl)-1-(4-(4-fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydropyridine | Mycobacterium tuberculosis H37Rv | IC50 | 0.5600 | 1 | 1 |
| 1-(3-(4-chlorobenzoyl)propyl)-4-hydroxy-4-(4-chlorophenyl)piperidine | Mycobacterium tuberculosis H37Rv | IC50 | 5.1000 | 1 | 1 |